A phase II trial of alternating cycles of carboplatin/paclitaxel and carboplatin/gemcitabine for stage IIIB/IV non-small cell lung cancer

被引：0
|
作者：
Ahmad, I. [1 ]
Arnold, F. [1 ]
Ahmed, S. [1 ]
Sami, A. [1 ]
Zhu, T. [1 ]
Haider, K. [1 ]
Yadav, S. [1 ]
Gesy, K. [1 ]
Brigden, M. [1 ]
机构：
[1] Saskatoon Canc Ctr, Saskatoon, SK, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19113
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Saleh, M. N.
    Socinski, M. A.
    Trent, D.
    Dobbs, T.
    Zehngebot, L. M.
    Levine, M. A.
    Stella, P. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)
    Bradford, D. S.
    Socinski, M. A.
    LaRocca, R. V.
    Hensing, T. A.
    Bordoni, R. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [5] Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer
    Sovak, Mika A.
    Lutzker, Stuart
    Zheng, Ling
    Guensch, Lisa
    Joyce, Margaret
    Schwartz, Susan
    Wu, Yujun
    Aisner, Joseph
    [J]. LUNG CANCER, 2006, 53 (02) : 177 - 181
  • [6] Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: Definitive results of a phase II trial
    Tassinari, D
    Fochessati, F
    Arcangeli, V
    Sartori, S
    Agostini, V
    Fantini, M
    Genestreti, G
    Grassia, S
    Ioli, G
    Imola, M
    Iorio, D
    Mianulli, AM
    Monticelli, G
    Oliverio, G
    Panzini, I
    Papi, M
    Poggi, B
    Polselli, A
    Pulini, S
    Tamburini, E
    Fattori, PP
    Ravaioli, A
    [J]. TUMORI JOURNAL, 2004, 90 (01): : 54 - 59
  • [7] Phase II study of navelbine and carboplatin in stage IIIB and IV non small cell lung cancer
    Chetiyawardana, AD
    Grove, N
    Faulk, S
    [J]. THORAX, 2001, 56 : 69 - 69
  • [8] A randomized phase II trial comparing pulsed erlotinib before or after carboplatin and paclitaxel in patients with stage IIIB or IV non-small cell lung cancer
    Riely, G. J.
    Rudin, C. M.
    Kris, M. G.
    Senturk, E.
    Azzoli, C. G.
    Brahmer, J.
    Fogle, M.
    Ginsberg, M.
    Miller, V. A.
    Rizvi, N. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    [J]. LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [10] Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer
    Abratt, Raymond P.
    Lee, Jung Sin
    Han, Ji Youn
    Tsai, Chun-Ming
    Boyer, Michael
    Mok, Ton
    Kim, Sang-We
    Lee, Jin Soo
    Brnabic, Alan J. M.
    Reece, William H. H.
    Lehnert, Manfred
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 135 - 140
12345